• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-琥珀酰壳聚糖载 5-氨基水杨酸系统用于结肠给药:在大鼠三硝基苯磺酸诱导结肠炎模型中的体内研究。

N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.

机构信息

Dept. Farmaco Chimico Tecnologico, University of Cagliari, Cagliari 09124, Italy.

出版信息

Int J Pharm. 2011 Sep 15;416(1):145-54. doi: 10.1016/j.ijpharm.2011.06.025. Epub 2011 Jun 23.

DOI:10.1016/j.ijpharm.2011.06.025
PMID:21723929
Abstract

5-Aminosalicylic acid (5-ASA) loaded N-Succinyl-chitosan (SucCH) microparticle and freeze-dried system were prepared as potential delivery systems to the colon. Physicochemical characterization and in vitro release and swelling studies were previously assessed and showed that the two formulations appeared to be good candidates to deliver the drug to the colon. In this work the effectiveness of these two systems in the treatment of inflammatory bowel disease was evaluated. In vitro mucoadhesive studies showed excellent mucoadhesive properties of both the systems to the inflamed colonic mucosa. Experimental colitis was induced by rectal instillation of 2,4,6-trinitrobenzene sulfonic acid (TNBS) into male Wistar rats. Colon/body weight ratio, clinical activity score system, myeloperoxidase activity and histological evaluation were determined as inflammatory indices. The two formulations were compared with drug suspension and SucCH suspension. The results showed that the loading of 5-ASA into SucCH polymer markedly improved efficacy in the healing of induced colitis in rats.

摘要

5-氨基水杨酸(5-ASA)负载 N-琥珀酰壳聚糖(SucCH)微球和冷冻干燥系统被制备为潜在的结肠递药系统。先前已经评估了其理化性质、体外释放和溶胀研究,结果表明这两种制剂似乎是将药物递送到结肠的良好候选物。在这项工作中,评估了这两种系统在治疗炎症性肠病中的有效性。体外黏膜黏附研究表明,两种系统对发炎的结肠黏膜均具有极好的黏膜黏附特性。通过直肠内注入 2,4,6-三硝基苯磺酸(TNBS)诱导雄性 Wistar 大鼠实验性结肠炎。将结肠/体重比、临床活动评分系统、髓过氧化物酶活性和组织学评估作为炎症指标进行测定。将这两种制剂与药物混悬液和 SucCH 混悬液进行了比较。结果表明,将 5-ASA 载入 SucCH 聚合物可显著提高治疗大鼠诱导性结肠炎的疗效。

相似文献

1
N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.N-琥珀酰壳聚糖载 5-氨基水杨酸系统用于结肠给药:在大鼠三硝基苯磺酸诱导结肠炎模型中的体内研究。
Int J Pharm. 2011 Sep 15;416(1):145-54. doi: 10.1016/j.ijpharm.2011.06.025. Epub 2011 Jun 23.
2
Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.生物黏附微丸可增加实验性结肠炎中局部 5-氨基水杨酸浓度。
Eur J Pharm Biopharm. 2012 Jun;81(2):379-85. doi: 10.1016/j.ejpb.2012.02.011. Epub 2012 Feb 22.
3
Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.评估5-氨基水杨基牛磺酸作为5-氨基水杨酸的结肠特异性前药用于治疗实验性结肠炎的效果。
Eur J Pharm Sci. 2006 May;28(1-2):26-33. doi: 10.1016/j.ejps.2005.12.005. Epub 2006 Feb 7.
4
Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.结肠特异性药物递送药代动力学模型的验证以及含5-氨基水杨酸的壳聚糖胶囊对2,4,6-三硝基苯磺酸诱导的大鼠结肠炎的治疗作用
J Pharm Pharmacol. 1999 Oct;51(10):1107-12. doi: 10.1211/0022357991776796.
5
Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.用于结肠特异性药物递送的壳聚糖胶囊:5-氨基水杨酸在大鼠大肠中的定位增强可加速三硝基苯磺酸诱导的结肠炎的愈合。
J Control Release. 2002 Jul 18;82(1):51-61. doi: 10.1016/s0168-3659(02)00084-6.
6
Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis.使用2,4,6-三硝基苯磺酸诱导的结肠炎大鼠模型对Eudragit包衣的壳聚糖-琥珀酰-泼尼松龙共轭微球的疗效和毒性研究
Int J Pharm. 2008 Jun 24;358(1-2):296-302. doi: 10.1016/j.ijpharm.2008.02.015. Epub 2008 Mar 10.
7
Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.壳聚糖-钙-海藻酸盐微粒实现5-氨基水杨酸的结肠特异性递送。
Int J Pharm. 2007 Sep 5;342(1-2):124-36. doi: 10.1016/j.ijpharm.2007.05.028. Epub 2007 May 21.
8
Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.LK-423 在结肠递药微囊中给药时治疗大鼠实验性结肠炎的疗效增强。
J Microencapsul. 2010;27(7):572-82. doi: 10.3109/02652048.2010.501393.
9
In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.用于结肠靶向的微生物群敏感涂层的体内功效:一种用于 IBD 治疗的有前途的工具。
J Control Release. 2015 Jan 10;197:121-30. doi: 10.1016/j.jconrel.2014.11.006. Epub 2014 Nov 10.
10
1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis.1,8-桉叶素(桉油精),一种单萜氧化物,可减轻急性三硝基苯磺酸诱导的大鼠结肠炎中的结肠损伤。
Food Chem Toxicol. 2004 Apr;42(4):579-84. doi: 10.1016/j.fct.2003.11.001.

引用本文的文献

1
Preparation and Characterization of a Novel Multiparticulate Dosage Form Carrying Budesonide-Loaded Chitosan Nanoparticles to Enhance the Efficiency of Pellets in the Colon.一种新型多颗粒剂型的制备与表征,该剂型载有布地奈德壳聚糖纳米颗粒以提高结肠中微丸的效率。
Pharmaceutics. 2022 Dec 26;15(1):69. doi: 10.3390/pharmaceutics15010069.
2
Budesonide-Loaded Hyaluronic Acid Nanoparticles for Targeted Delivery to the Inflamed Intestinal Mucosa in a Rodent Model of Colitis.载布地奈德透明质酸纳米粒在结肠炎啮齿动物模型中靶向递送至炎症性肠黏膜。
Biomed Res Int. 2022 Sep 27;2022:7776092. doi: 10.1155/2022/7776092. eCollection 2022.
3
Optimization of Multilayer Films Composed of Chitosan and Low-Methoxy Amidated Pectin as Multifunctional Biomaterials for Drug Delivery.
壳聚糖和低甲氧基酰胺化果胶组成的多层膜作为多功能药物输送生物材料的优化。
Int J Mol Sci. 2022 Jul 22;23(15):8092. doi: 10.3390/ijms23158092.
4
Formulation, Development and Evaluation of Budesonide Oral Nano-sponges Using DOE Approach: Evidences.采用实验设计方法对布地奈德口服纳米海绵进行制剂、开发与评价:证据
Adv Pharm Bull. 2021 Feb;11(2):286-294. doi: 10.34172/apb.2021.041. Epub 2020 Aug 5.
5
Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory Bowel Disease.海洋衍生的强韧生物分子在炎症性肠病管理中的应用。
Mar Drugs. 2021 Mar 30;19(4):196. doi: 10.3390/md19040196.
6
Development of Mucoadhesive Chitosan Derivatives for Use as Submucosal Injections.用于粘膜下注射的粘膜粘附性壳聚糖衍生物的研发。
Polymers (Basel). 2018 Apr 6;10(4):410. doi: 10.3390/polym10040410.
7
A novel lidocaine hydrochloride mucoadhesive films for periodontal diseases.一种用于牙周病的新型盐酸利多卡因粘膜粘附膜。
J Mater Sci Mater Med. 2019 Jan 11;30(1):14. doi: 10.1007/s10856-018-6213-7.
8
Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease.医药策略的进展提高了炎症性肠病口服结肠靶向递药系统的效率。
Molecules. 2018 Jul 4;23(7):1622. doi: 10.3390/molecules23071622.
9
Protective effects of conventional and colon-targeted lycopene and linalool on ulcerative colitis induced by acetic acid in rats.常规及结肠靶向番茄红素和芳樟醇对大鼠乙酸诱导的溃疡性结肠炎的保护作用。
Inflammopharmacology. 2018 May 7. doi: 10.1007/s10787-018-0485-x.
10
Natural and synthetic polymer-based smart biomaterials for management of ulcerative colitis: a review of recent developments and future prospects.基于天然和合成聚合物的智能生物材料在溃疡性结肠炎治疗中的应用:最新进展及未来展望的综述。
Drug Deliv Transl Res. 2019 Apr;9(2):595-614. doi: 10.1007/s13346-018-0512-x.